The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera [5]

British Journal of Haematology

Volumn 130, Issue 5, 2005, Pages 800-801

  Cario, Holger ^a   Goerttler, Philipp S ^b   Steimle, Cordula ^b   Levine, Ross L ^c   Pahl, Heike L ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Myeloproliferative disorders

Indexed keywords

JANUS KINASE 2; JAK2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ALLELE; CHROMOSOMAL LOCALIZATION; DISEASE PREDISPOSITION; FAMILIAL DISEASE; GENE MUTATION; GENETIC LINKAGE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LETTER; MYELOPROLIFERATIVE DISORDER; PHENOTYPE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; ADOLESCENT; ADULT; AGED; BIOLOGICAL MODEL; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PEDIGREE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MODELS, GENETIC; MYELOPROLIFERATIVE DISORDERS; PEDIGREE; POLYCYTHEMIA VERA; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 27244450853     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05683.x     Document Type: Letter

References (6)

1. Baxter E.J. Scott L.M. Campbell P.J. East C. Fourouclas N. Swanton S. Vassiliou G.S. Bench A.J. Boyd E.M. Curtin N. Scott M.A. Erber W.N. Green A.R. ( 2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 1054 1061.
2. Cario H. Pahl H.L. Schwarz K. Galm C. Hoffmann M. Burdelski M. Kohne E. Debatin K.M. ( 2003) Familial polycythemia vera with Budd-Chiari syndrome in childhood. British Journal of Haematology, 123, 346 352.
3. James C. Ugo V. Le Couedic J.P. Staerk J. Delhommeau F. Lacout C. Garcon L. Raslova H. Berger R. Bennaceur-Griscelli A. Villeval J.L. Constantinescu S.N. Casadevall N. Vainchenker W. ( 2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 1144 1148.
4. Kralovics R. Stockton D.W. Prchal J.T. ( 2003) Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood, 102, 3793 3796.
5. Kralovics R. Passamonti F. Buser A.S. Teo S.S. Tiedt R. Passweg J.R. Tichelli A. Cazzola M. Skoda R.C. ( 2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, 352, 1779 1790.
6. Levine R. Wadleigh M. Cools J. Ebert B. Wernig G. Huntley B. Boggon T. Wlodarska I. Clark J. Moore S. Adelsperger J. Koo S. Lee J. Gabriel G. Mercher T. D'Andrea A. Fröhling S. Döhner K. Marynen P. Vandenberghe P. Mesa R. Tefferi A. Griffin J. Eck M. Sellers W. Meyerson M. Golub T. Lee S. Gilliland D. ( 2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 4, 387 397.